Study of LQT-1213 on Dofetilide-Induced QTc Prolongation in Healthy Adult Subjects and Patients Diagnosed With Type 2 or 3 Long QT Syndrome

Condition:   Long QT Syndrome Interventions:   Drug: LQT-1213;   Drug: Placebo;   Drug: Dofetilide 250 μg Cap Sponsor:   Thryv Therapeutics, Inc. Active, not recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials